Artiva Biotherapeutics, Inc. ( ARTV) - Stock Earnings
ARTV Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 11, 2026, midnight | — / — | — | — / — | — |
ARTV Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -20.8 million USD | — USD |
| 2026Q1 | -23.5 million USD | — USD |
| 2026Q2 | -25.0 million USD | — USD |
| 2027Q2 Est. | — | — |
ARTV Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -27.7 million USD | 33.5 million USD |
| 2024 | -58.5 million USD | 251000 USD |
| 2025 | -83.9 million USD | — USD |
| 2026 Est. | — | — |
ARTV
Price: $6.77
52 week price:
Earnings Per Share: -3.23 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 355.4 million